Let's make life easier in life sciences.
Eligibility ... automatically. Learn how Irix can help you enroll the right participants faster, reduce site burden, flag adverse events and protocol deviations, and ensure your clinical trial’s integrity.
Page
Quickly and easily include or exclude participants at every stage of your unique clinical trial.
Irix empowers you to enroll the right participants faster, reduce site burden, flag adverse events and protocol deviations, and ensure your trial’s integrity.
With basic participant information and a HIPAA authorization, Milliman IntelliScript can instantly return years of interpreted, structured prescription histories and medical claims data on nearly any U.S. individual.
There’s no need to sift through error-prone questionnaires and interview notes for trial recruitment or rely on participants to monitor changes that threaten their continued eligibility. Instead, we configure our fully automated Irix Rules Engine to spot your trial’s inclusion and exclusion criteria in a wealth of health data. The Rules Engine interprets each participant’s Prescription Data and Medical Data to determine eligibility—so you can identify qualified participants or confirm continued eligibility in seconds.
Recruiters, sites, CROs, and sponsors are using this secure, thoroughly operationalized, and game-changing technology.
Stop relying on participants’ memories, digging through notes, or running unnecessary labs. Our unique SaaS solution is affordable, accurate, secure, and backed by great customer service. Talk to us about piloting Irix to help you:
Eligibility ... automatically. Learn how Irix can help you enroll the right participants faster, reduce site burden, flag adverse events and protocol deviations, and ensure your clinical trial’s integrity.
Milliman and our third-party website analytics and performance partners use cookies on our website that may collect and use personal information in order to constantly improve website performance and reliability and to provide accurate and relevant information. By clicking “Accept,” you consent to the placement and use of cookies by Milliman and our third-party partners for these purposes. You can learn more about how this site uses cookies and related technologies by reading our privacy policy